Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
128 hedge funds and large institutions have $375M invested in Spectrum Pharmaceuticals Inc in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 52 increasing their positions, 39 reducing their positions, and 22 closing their positions.
108% more call options, than puts
Call options by funds: $1.39M | Put options by funds: $670K
33% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 39
20% more capital invested
Capital invested by funds: $314M → $375M (+$61.5M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 137 → 128 (-9)
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$11.7M |
| 2 |
AC
Armistice Capital
New York
|
+$11M |
| 3 |
KAM
Krensavage Asset Management
New York
|
+$5.36M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.75M |
| 5 |
Renaissance Technologies
New York
|
+$2.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$6.79M |
| 2 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
-$3.81M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$2.43M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.28M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$1.2M |
SPPI Hedge Fund Activity: Q2 2015 in Review
128 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2015, worth a combined $375M — up 20% from $314M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of SPPI and 13 opened new positions — a net loss of 9 holders — while 39 trimmed existing stakes and 52 added.
The largest buyer was Broadfin Capital, adding an estimated $11.7M. The largest seller was Citadel Advisors, exiting entirely with an estimated $6.79M sold.
- 128 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2015, down from 137 in Q1 2015.
- Funds reported $375M of Spectrum Pharmaceuticals Inc stock for Q2 2015, up 20% quarter-over-quarter.
- 13 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2015 and 22 closed out, a net change of -9 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q2 2015 was Broadfin Capital, an estimated $11.7M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q2 2015 was Citadel Advisors, an estimated $6.79M sold.
Based on aggregated 13F filings for Q2 2015.